Author:
Struck H. G.,Giessler Ch.,Erfurt I.,Mentz P.,Mest H.-J.,Tost M.
Publisher
Springer Berlin Heidelberg
Reference21 articles.
1. Anderson JA, Chen Ch Ch (1988) Multiple dosing increases the ocular biovailability of topically administered flurbiprofen. Arch Ophthalmol (Chicago) 106:1107–1109
2. Arate M, Sawa M, Takase M (1983) Topical flurbiprofen and diclofenac suppress blood-aqueous barrier breakdown in cataract surgery: a fluorophotometrie study. Jpn J Ophthalmol 27:535–542
3. Arate M, Takase M (1985) Effects of S — 596 and Carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: a fluorophotometrie study. Graefes Arch Klin Exp Ophthalmol 222:259–262
4. Bazan HEP, Birkle DL, Beuerman RW, Bazan NG (1985) Inflammation-induced Stimulation of the synthesis of Prostaglandins and lipoxygenase-reactionproduets in rabbit cornea. Curr Eye Res 4:175–179
5. Brodgen RN, Heel RC, Speight TM (1979) Flurbiprofen: A review ofits pharmacological properties and therapeutic use in rheumatic diseases. Drugs 18:417–438